TrialRheumatology (Oxford, England)2019

Safety and tolerability of subcutaneous sarilumab and intravenous tocilizumab in patients with rheumatoid arthritis.

Paul Emery et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.